Recent Posts
June 14

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities
A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor...
Oncology Exchange
read more
June 10

Novel Therapy Shows Promise in Group of Patients with Metastatic Colon Cancer
Patients with HER2-expressing metastatic colorectal cancer appeared to achieve durable and promising...
Oncology Exchange
read more
June 10

Provectus Biopharmaceuticals Announces Publication of In Vitro Data from Research on Oral Delivery of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
KNOXVILLE, TN, June 09, 2021 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that...
Oncology Exchange
read more
June 10

Advarra expands Gene Therapy Ready network with 500+ sites
June 9, 2021 -- Advarra's Gene Therapy Ready network has grown to over 500 registered research...
Oncology Exchange
read more
June 10

Old antidepressants show promise as immuno-oncology treatments in melanoma and colon cancer
A class of antidepressants known as monoamine oxidase inhibitors (MAOIs) first hit the market in the...
Oncology Exchange